Contributions of SyringeSybille

Contributions by SyringeSybille, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 3,011 edits includes activity predating the current log.

1. 07:26, 22 Jun 2026 (diff | hist) Syringe dead space 20,968 ±0 m add the note that a smaller diluent volume raises concentration, not dose
2. 22:57, 16 Jun 2026 (diff | hist) Oral semaglutide 4,582 ±0 clarify that the peptide backbone is acylated rather than PEGylated
3. 12:54, 11 Jun 2026 (diff | hist) Sharps disposal 15,972 +1,295 correct the unit conversion — U-100 not U-40
4. 08:33, 26 May 2026 (diff | hist) Sharps disposal 6,565 +674 clarify that the figure is per dose, not per vial
5. 14:25, 14 May 2026 (diff | hist) Talk:Subcutaneous injection 748 +132 /* Needle length and intramuscular delivery */ reply
6. 10:35, 17 Apr 2026 (diff | hist) Talk:Insulin syringe 537 +155 /* Percentage-of-full-scale accuracy */ new section
7. 09:27, 18 Feb 2026 (diff | hist) Talk:Syringe dead space 959 +254 /* Needle lumen table — computed or measured? */ reply
8. 18:00, 30 Jan 2026 (diff | hist) Dose escalation schedule 4,993 ±0 correct the needle gauge given for subcutaneous administration
9. 07:41, 15 Jan 2026 (diff | hist) Subcutaneous injection 5,293 ±0 add a second worked example at a different vial strength
10. 11:47, 14 Jan 2026 (diff | hist) Talk:Insulin syringe unit conversion 1,033 +192 /* Is the U-40 material needed at all? */ reply
11. 17:17, 20 Nov 2025 (diff | hist) Dose escalation schedule 4,993 ±0 expand §Deviations and their consequences
12. 08:15, 4 Nov 2025 (diff | hist) Talk:Syringe dead space 822 +185 /* The 35% figure is being cited elsewhere as an unconditional dose error */ reply
13. 07:17, 15 Oct 2025 (diff | hist) Satiety signalling 5,593 ±0 add the species in which the knockout work was done
14. 22:15, 25 Sep 2025 (diff | hist) Shanghai Sigma-Audley New Material Technology 13,175 ±0 attribute the documentation description to the purchaser reports it comes from
15. 17:40, 16 Sep 2025 (diff | hist) Shenzhen Hybio Pharmaceutical 4,766 +33 m rm the comparison with another supplier; there is no common basis for it
16. 15:47, 21 Aug 2025 (diff | hist) Talk:Reconstitution calculator 885 +186 /* Dead space: delivered dose or vial yield? */ reply
17. 04:21, 4 Aug 2025 (diff | hist) Good manufacturing practice 5,123 ±0 add the telehealth prescribing point as attributed
18. 09:55, 19 Jul 2025 (diff | hist) Subcutaneous injection 4,640 ±0 rm the individualised advice — the article describes, it does not instruct
19. 08:43, 26 May 2025 (diff | hist) Beyond-use date 13,672 ±0 m add the shelf life after first puncture, attributed
20. 03:06, 25 Apr 2025 (diff | hist) Dose escalation schedule 4,073 ±0 m expand §Representative schedules
21. 14:45, 23 Apr 2025 (diff | hist) Multi-dose vial 12,489 +1,238 expand §Definition and compendial basis
22. 09:00, 16 Apr 2025 (diff | hist) Temperature excursion 3,239 +3,239 N create article — process stub
23. 12:41, 25 Mar 2025 (diff | hist) Talk:Multi-dose vial 748 +290 /* Merge proposal from Vial — response */ reply
24. 20:53, 13 Mar 2025 (diff | hist) Hunan Aslsen Technology 8,485 +764 add the standing talk-page note link to the banner
25. 23:26, 20 Feb 2025 (diff | hist) Bacteriostatic water 3,824 ±0 m fix a broken wikilink
26. 14:08, 7 Feb 2025 (diff | hist) Beyond-use date 10,475 +688 add the sharps-disposal cross-link
27. 01:48, 13 Dec 2024 (diff | hist) Chinese Peptide Company 7,202 +523 m British spelling per PP:MOS
28. 03:23, 27 Nov 2024 (diff | hist) Dose escalation schedule 2,748 +29 add the disclaimer that this is not administration guidance
29. 09:00, 25 Nov 2024 (diff | hist) Active pharmaceutical ingredient 1,143 +1,143 N start article on the regulatory position
30. 07:05, 5 Sep 2024 (diff | hist) Sterile water for injection 1,810 ±0 correct the label on the second column — that is volume, not mass